Target Name: OR10H5
NCBI ID: G284433
Review Report on OR10H5 Target / Biomarker Content of Review Report on OR10H5 Target / Biomarker
OR10H5
Other Name(s): Olfactory receptor OR19-25 | Olfactory receptor 10H5 | OR19-26 | olfactory receptor 10H5 | olfactory receptor family 10 subfamily H member 5 | O10H5_HUMAN | olfactory receptor OR19-25 | olfactory receptor OR19-26 | Olfactory receptor OR19-26 | OR19-25 | Olfactory receptor family 10 subfamily H member 5

Potential Drug Target/Biomarker for Olfactory System

Olfactory receptor OR10H5 is a G protein-coupled receptor (GPCR) that is expressed in the olfactory system, which is responsible for detecting and recognizing scents. OR10H5 is one of the many GPCRs that have been identified as potential drug targets or biomarkers for various diseases , including cancer, neurodegenerative diseases, and psychiatric disorders.

The olfactory system is a complex organ that is responsible for the sense of smell. It is made up of the nose, the turbinate bones in the nasal cavity, and the olfactory bulbs, which contain the olfactory cells. The olfactory system is involved in many aspects of human life, including daily activities such as cooking, cleaning, and interacting with the environment.

OR10H5 is a GPCR that is expressed in the olfactory system and is involved in the sense of smell. It is a member of the T cell receptor family, which is a family of GPCRs that are involved in cell signaling. OR10H5 is expressed in the olfactory bulbs and is involved in the detection of scents, including odors and chemicals.

Due to its involvement in the sense of smell, OR10H5 has been identified as a potential drug target or biomarker for various diseases. One of the main reasons for this is the fact that changes in the levels of OR10H5 have been associated with the development and progression of several diseases. For example, studies have shown that altered levels of OR10H5 have been associated with the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target or biomarker, OR10H5 has also been identified as a potential biomarker for certain diseases. For example, studies have shown that OR10H5 levels are elevated in the olfactory bulbs of individuals with Alzheimer's disease, which could be used as a diagnostic marker for this disease. Additionally, OR10H5 levels have been shown to be elevated in the olfactory bulbs of individuals with cancer, which could be used as a biomarker for this disease.

Another potential use for OR10H5 is as a target for drug development. By blocking the action of OR10H5, drugs can be developed that are capable of treating diseases that are caused by changes in the levels of this receptor. For example, drugs that are designed to block the action of OR10H5 have been shown to be effective in treating certain forms of cancer.

OR10H5 is also a good candidate as a potential drug target because of its unique structure and the fact that it is expressed in only one tissue in the body. This makes it easier to study its function and to develop drugs that target it specifically.

In conclusion, OR10H5 is a GPCR that is expressed in the olfactory system and is involved in the sense of smell. It has been identified as a potential drug target or biomarker for a variety of diseases, including neurodegenerative diseases, cancer, and psychiatric disorders. Further research is needed to fully understand its function and to develop drugs that target it specifically.

Protein Name: Olfactory Receptor Family 10 Subfamily H Member 5

Functions: Odorant receptor

The "OR10H5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR10H5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P | OR14A16 | OR14A2 | OR14C36 | OR14I1 | OR14J1 | OR14L1P | OR1A1 | OR1A2 | OR1B1 | OR1C1 | OR1D2 | OR1D4 | OR1D5 | OR1E1 | OR1E2 | OR1E3 | OR1F1 | OR1F2P | OR1G1 | OR1I1 | OR1J1 | OR1J2 | OR1J4 | OR1K1 | OR1L1 | OR1L3 | OR1L4 | OR1L6 | OR1L8 | OR1M1 | OR1N1 | OR1N2 | OR1P1 | OR1Q1 | OR1S1 | OR1S2 | OR2A1 | OR2A1-AS1 | OR2A12 | OR2A14 | OR2A2 | OR2A20P | OR2A25 | OR2A4 | OR2A42 | OR2A7 | OR2A9P | OR2AE1 | OR2AG1 | OR2AG2 | OR2AJ1 | OR2AK2 | OR2AL1P | OR2AM1P | OR2AP1 | OR2AT4